SARS-CoV-2 Variants

What is the Impact of the Delta Variant?

The Delta Variant is 55% more virulent than the Alpha Variant. Evidence shows that it can evade antibody-based treatments and that it can potentially increase the risk of reinfection in people who have recovered from COVID caused by another strain.

Take a look at the infographic below for more insight on the impact of the Delta Variant:

You may be interested in the following article:

A Comparative Framework Between New Product and Legacy Product Process Validation

This paper is a comparative analysis between the application of the FDA Process Validation Guidance (2011) to new products and legacy products.